Development of a non-invasive Polymerase Chain Reaction molecular diagnostic procedure to detect Helicobacter Pylori

开发非侵入性聚合酶链反应分子诊断程序来检测幽门螺杆菌

• 批准号: 515630-2017
• 负责人: Williamson, Vanessa
• 金额: $ 1.06万
• 依托单位: Seneca College of Applied Arts and Technology
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 1
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=641654
• 关键词: Development; non; invasive; Polymerase; Chain

Spartan Bioscience (Spartan) is a leading biotechnology company in Ontario which develops point-of-care medical device platforms for DNA diagnostics. Through this collaboration with Seneca, Spartan will expand their product offering to include a non-invasive test for Helicobacter Pylori, the cause of 60% of all stomach cancers (the third leading cause of cancer death in China). Once commercialized, this new diagnostic test will be sold in China, opening up a new international market for Spartan.

Spartan Bioscience（Spartan）是安大略的一家领先的生物技术公司，开发用于DNA诊断的即时医疗设备平台。通过与Seneca的合作，Spartan将扩大其产品范围，包括幽门螺杆菌的非侵入性检测，幽门螺杆菌是导致60%胃癌的原因（中国癌症死亡的第三大原因）。一旦商业化，这种新的诊断测试将在中国销售，为Spartan开辟新的国际市场。